Pharmaceutical Manufacturers To Benefit From Consistency And Clarity

Main Category: Pharma Industry / Biotech Industry
Article Date: 22 Oct 2009 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


To improve key documentation relied upon by the pharmaceutical industry and others, the U.S. Pharmacopeial (USP) Convention announces the release of the redesigned United States Pharmacopeia-National Formulary (USP-NF). The new format brings consistency and clarity to language and formats used throughout the publication, greatly improving ease of use. USP has produced this book of written standards for the identity, quality, purity, and strength of medicines and their ingredients since 1820. Official compendial standards such as those in the USP-NF are written into United States law as part of the adulteration and misbranding provisions of the Federal Food, Drug, and Cosmetic Act of 1938. The current redesign marks the first time that all monographs in the USP-NF appear in a consistent, coordinated format.

"USP has been setting pharmaceutical standards for almost 200 years, and the terminology and formatting used in our collection of monographs reflect many different eras and editorial styles," said Susan de Mars, USP's chief documentary standards officer. "This redesign brings consistency to the language used throughout the book and weaves the text into a new outline and format that makes it easier for readers to find - and to understand - what they're looking for."

Customers and other users of the USP-NF have provided extensive input for the redesign over the past few years. Working with this input and members of the volunteer USP Council of Experts, USP staff developed a new template with the primary goal of enhancing usability. Changes include: The current redesign has focused only on language and formatting. Any potential changes to scientific content are treated separately for each monograph through the processes described at http://www.usp.org/USPNF/. The redesigned format will be incorporated in USP 33-NF 28 in November 2009.

Source:
Francine Pierson
US Pharmacopeia

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Francine Pierson. "Pharmaceutical Manufacturers To Benefit From Consistency And Clarity." Medical News Today. MediLexicon, Intl., 22 Oct. 2009. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/168199.php>

APA
Francine Pierson. (2009, October 22). "Pharmaceutical Manufacturers To Benefit From Consistency And Clarity." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/168199.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »